Beauty products company Elizabeth Arden (NASDAQ: RDEN) missed analysts' estimates by a country mile when it reported last week, posting a per-share loss of $0.86 versus a forecast of $0.47. Quarterly sales dropped 9% on weakness in its fragrance segment.
The chart also shows a company in trouble. Shares have broken support dating back to August's capitulation low, and with a score of 32, the odds favor continued selling.
No comments:
Post a Comment